Synergistic suppression of noscapine and conventional chemotherapeutics on human glioblastoma cell growth. - Wikidata - wikimedia - TriplyDB

Synergistic suppression of noscapine and conventional chemotherapeutics on human glioblastoma cell growth.

Synergistic suppression of noscapine and conventional chemotherapeutics on human glioblastoma cell growth.

http://www.wikidata.org/entity/Q37728530

about

The Noscapine Chronicle: A Pharmaco-Historic Biography of the Opiate Alkaloid Family and its Clinical Applications Investigations on Antioxidant, Antiproliferative and COX-2 Inhibitory Potential of Alkaloids from Anthocephalus cadamba (Roxb.) Miq. Leaves.Quercetin sensitizes human glioblastoma cells to temozolomide in vitro via inhibition of Hsp27.Noscapine chemosensitization enhances docetaxel anticancer activity and nanocarrier uptake in triple negative breast cancer Temozolomide-Mediated Apoptotic Death Is Improved by Thymoquinone in U87MG Cell Line.Delivery of a drug cache to glioma cells overexpressing platelet-derived growth factor receptor using lipid nanocarriers Targeting breast cancer cells with a CuInS2/ZnS quantum dot-labeled Ki-67 bioprobe.

P2860

Q26801133-48DB9961-B12D-4A5B-911E-28ED1D19B7E1 Q32183944-5F2CF4A0-6B0B-41CB-8738-A3850519BA9A Q33861890-8838DBE7-D0AC-478C-B527-68F9531F9AF0 Q37426564-F5577E51-E4A5-4B92-B6C3-3A67D40CFD26 Q38709774-D1BEF7DA-1257-4C53-BCEB-458EE68494F3 Q38784169-AF1AA9A0-2DE2-409C-8EE6-79550CC3B201 Q49740554-07D80FCF-7D32-4B8E-A555-4886768094F8

P2860

Synergistic suppression of noscapine and conventional chemotherapeutics on human glioblastoma cell growth.

http://www.wikidata.org/entity/Q37728530

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 May 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Synergistic suppression of nos ...... uman glioblastoma cell growth.

@en

Synergistic suppression of nos ...... uman glioblastoma cell growth.

@nl

type

label

Synergistic suppression of nos ...... uman glioblastoma cell growth.

@en

Synergistic suppression of nos ...... uman glioblastoma cell growth.

@nl

prefLabel

Synergistic suppression of nos ...... uman glioblastoma cell growth.

@en

Synergistic suppression of nos ...... uman glioblastoma cell growth.

@nl

P1433

Q37728530-324D4C2E-75EC-41D2-B090-52BD3334534E

P1476

Q37728530-6219DC77-EC72-4D0A-8438-F9DAE52DBEE3

P2093

Q37728530-04746ED7-0C16-431B-8910-3625E060750B

Q37728530-224DE2F7-6F74-4EEE-A608-57B97B096CA7

Q37728530-3F4B23B3-50E5-466B-904B-E9E291C09404

Q37728530-D92FC688-5778-40D8-B736-B3ED671123D5

Q37728530-DA2ADD72-7D09-438B-8506-C14F1116DB6B

P2860

Q37728530-13F2C7D0-F4EC-4EAE-A91F-943FAF66C4FD

Q37728530-207B48AB-3449-4440-B022-1FAA11E2F891

Q37728530-2F277EA8-8971-4B5F-A15E-BCC0D73DC879

Q37728530-3079E5A3-FC9C-4312-A3A0-165407F0E9A1

Q37728530-32D2B748-B2C9-49AE-B500-D6C7C5093A01

Q37728530-411EDC03-C3E0-4606-ADE4-B5A5AD2121F5

Q37728530-4A91BE5C-68D8-4BB2-83E4-3507981770DD

Q37728530-4B362601-6A98-4824-A523-6DBADD4B3383

Q37728530-523B8DA5-B3F6-4FAA-B009-959CCE7F8CD9

Q37728530-58146D0C-0DA3-4537-8D48-B88301349E47

P2888

Q37728530-FC4AA038-D509-4F02-BD83-EE95A00084BE

P304

Q37728530-423F59EE-BD86-4C92-9048-07FBAE9CBC67

P31

Q37728530-3AB8353B-39D6-4A19-AA06-9623FDB86420

P356

Q37728530-92AD1941-FC5B-4F8A-88C7-30E184F36D79

P433

Q37728530-13A7D8A2-4819-40DC-8621-0B264365A469

P478

Q37728530-ACB5B2A0-87BF-4F96-A658-F115665D8E8F

P577

Q37728530-EB25D894-AAAC-4FC1-9439-2EF834B4F5E3

P5875

Q37728530-39A5016E-DA4B-41B7-A342-3275C3F60BC9

P6179

Q37728530-4F5F4AFC-F8A5-4708-A08E-FCF7CB70CA90

P698

Q37728530-59B01C18-2F96-4CE1-BB2B-6C2C611304CC

P921

Q37728530-6F1F056E-5452-4253-A733-D6B5A0BFEDD8

P932

Q37728530-C5C6D1D5-64A8-4AE4-956E-DF7F7026E108

P356

P1433

Acta Pharmacologica Sinica

P1476

Synergistic suppression of nos ...... uman glioblastoma cell growth.

@en

P2093

Harish C Joshi

http://www.w3.org/2001/XMLSchema#string

Keqiang Ye

http://www.w3.org/2001/XMLSchema#string

Qi Qi

http://www.w3.org/2001/XMLSchema#string

Shiyong Li

http://www.w3.org/2001/XMLSchema#string

Xia Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies

Temozolomide in combination with BCNU before and after radiotherapy in patients with inoperable newly diagnosed glioblastoma multiforme.

Possible novel therapy for malignant gliomas with secretable trimeric TRAIL.

A novel microtubule-modulating agent induces mitochondrially driven caspase-dependent apoptosis via mitotic checkpoint activation in human prostate cancer cells.

Attachment and tension in the spindle assembly checkpoint.

Targeting microtubules for cancer chemotherapy.

The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas.

Microtubule inhibitors: Differentiating tubulin-inhibiting agents based on mechanisms of action, clinical activity, and resistance.

Opium alkaloid noscapine is an antitumor agent that arrests metaphase and induces apoptosis in dividing cells

P2888

P304

930-938

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/APS.2013.40

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236939701

http://www.w3.org/2001/XMLSchema#string

P6179

1035858326

http://www.w3.org/2001/XMLSchema#string

P698

23708557

http://www.w3.org/2001/XMLSchema#string

P921

P932

4002615

http://www.w3.org/2001/XMLSchema#string